All strategy articles – Page 2
-
News
EPSRC head pledges greater dialogue with researchers
UK physical sciences chief Philip Nelson talks exclusively to Chemistry World about his plans, doctoral training and discontent in the community
-
News
Home secretary’s student visa plan draws ire of science community
Foreign students would be expelled from UK as soon as they complete their degrees
-
News
UK science strategy leaves many questions unanswered
Document contains no commitment to continue science ringfence or increase R&D spending
-
News
Sweden pushes for research to boost industry
New government see cooperation between science and industry as way to reindustrialise the country
-
News
Science roadmap for next parliament unveiled
UK Campaign for Science and Engineering wants funding to match US levels and VAT exemptions for R&D
-
Business
Bayer to sever polymer arm
German chemical giant’s exit from the materials world will help fund its crop and healthcare ambitions
-
News
Australia's chief scientist makes pitch for science
Ian Chubb calls on the government to set out a long-term plan for research, but there are doubts the plea will be heard
-
News
Future direction of Dutch science considered
Role of private industry heads a number of issues that confront how science is put to work for society
-
News
Indian scientists applaud research budget
Fears that the government would cut science funding proved unfounded as more money is made available
-
News
US plans 30% emissions cuts for power plants
The Obama administration’s proposed Clean Power Plan has been well-received by environmental groups, but attacked by industry
-
News
Synthetic biology vision for Europe unveiled
Chemistry will contribute to nascent field with applications across medicine, chemicals and agriculture
-
Business
Chemistry will underpin economic growth, say industry leaders
The UK chemical sector needs to rebuild supply chains and present a unified voice to government
-
Business
Pharma industry 'strategic crisis'
The problem is shrinking margins, caused by price and cost pressure, regulatory change and expiring patents, report says
-
Business
Novartis biotech plant for Singapore
Firm will invest $500 million in biotech manafacturing
-
Business
BASF backs automotive growth
While other chemical companies are trying to reduce their exposure to the automotive industry, BASF is heading in the other direction
- Previous Page
- Page1
- Page2
- Next Page